PATENT CLAIM ANALYSIS

Application Number: 16069932
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-01
Patent Classification: ["530", "399000"]

Abstract:
The invention relates to compounds derived from the EGF(A) domain of LDL-R, in particular compounds comprising a peptide analogue of the wild-type EGF(A) (LDL-R(293-332)) sequence and at least one substituent comprising at least one fatty acid group. The invention also relates to a pharmaceutical composition thereof and use a medicament. The novel EGF(A) compounds of the invention are useful as treatment e.g. in the field of cholesterol lowering, dyslipidaemia and cardiovascular disease.

Claim (Index 20):
The EGF(A) peptide analogue according to  claim 12 , further comprising one, two, three, four or all five of the following (wild type) amino acid residue(s): 295Asn, 296Glu, 298Leu, 302Gly and 310Asp.

Metadata:
- Claim Count in Document: 13.0
- Percentile: 95.0
- Lexical Diversity: 1.76923
- Patent Class: 530.0
- Transitional Phrase Type: open
- Component Type: 1
- Foreign Priority: True
- Related Applications: ['15301960', '15966642', '15404808', '14399087', '15315985']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6946558156184026
- 35 USC 102 Novelty (BERT): 0.5200430093750101
- Combined Prediction Score: 0.6771945349940633
- Mean Citation Score: 307.498832
- Max Citation Score: 329.66962
- Similarity Product: 228.24042438056827

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test